Global Melanoma Cancer Market, Global Market Size, Forecast 2018-2023 MALONEMA _MARKET | Page 2

Global melanoma cancer market: global market size, industry growth, future
prospects, opportunities and forecast 2018-2023
“Orion Market Research (OMR) recently published a market research report on global melanoma cancer
market. It is estimated that the market is augmenting with a noteworthy growth rate during the forecast
period 2018-2023. The market is augmenting due to increasing incidence of melanoma globally and
rising ozone layer depletion due to global warming are the major factor driving the market during
forecast period. The global melanoma cancer market is segmented on the basis of cancer type, therapy
and by diagnosis method. The report provides detailed and insightful chapters which includes market
overview, key findings, strategic recommendations, market estimations, market determinants, key
company analysis, market insights, company profiling, market segmentation, geographical analysis,
analyst insights of the market.”
Browse For The Full Report At: https://www.omrglobal.com/industry-reports/melanoma-cancer-market/
Melanoma develops due to unrepaired DNA damage to skin cells due to expose of skin to ultraviolet
radiation. The exposer triggers mutation which causes skin cells to multiply rapidly and form malignant
tumors. Although it is not the most common skin cancers, however, it causes most deaths. As per
American Medical Association, the total incident cases of the melanoma in 2015 were more than
352,000 with a growth of 56% as compared to 2005 globally. It has high prevalence rate in the
developed economies such as the US, Germany, France, Italy, Australia and Canada. Australia has
significant high prevalence of melanoma as it was the 4th leading cancer in 2015 in the region. In
Germany it is the 5th leading cancer and 6th leading cancer in the UK, & the US. As per Skin Cancer
Foundation, more than 87,000 new cases related to melanoma were registered in the US in 2017 and
estimated mortality due to melanoma is near to 9,700. In Australia, as per Cancer Australia, estimated
cases of the melanoma in 2018 are about 14,300 and expected mortality is near to 1,900. It is expected
that melanoma has over 10% share to all new cancer cases in 2018. Similarly, as per Cancer Research UK
16,000 new cases are registered in the UK in 2015.